DNA
Ginkgo Bioworks Holdings, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +2.2% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 74 | +5 | 25.52M | $252.75M | +9 | −4 |
| Q1 2026 | 72 | -1 | 23.15M | $141.95M | +6 | −7 |
| Q4 2025 | 73 | +2 | 24.08M | $200.09M | +2 | — |
| Q3 2025 | 15 | -2 | 16.22M | $236.55M | — | −2 |
| Q2 2025 | 14 | 0 | 15.99M | $179.94M | +2 | −2 |
| Q1 2025 | 11 | -3 | 10.22M | $58.26M | — | −3 |
| Q4 2024 | 14 | +3 | 10.20M | $100.21M | +3 | — |
| Q3 2024 | 10 | -3 | 9.70M | $79.02M | — | −3 |
| Q2 2024 | 13 | — | 419.17M | $140.02M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Viking Global Investors ✦ | 3.58M | 0.0% | $40.24M | 0.1% | Held | 5 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 3.28M | -2.2% | $36.86M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 3.28M | -2.2% | $36.86M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 3.28M | -2.2% | $36.86M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 5 | Baillie Gifford ✦ | 3.28M | -2.2% | $36.86M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 3.05M | — | $34.31M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 3.05M | — | $34.31M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 3.05M | — | $34.31M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 3.05M | — | $34.31M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 3.05M | — | $34.31M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 3.05M | — | $34.31M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 3.05M | — | $34.31M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 3.05M | — | $34.31M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 3.05M | — | $34.31M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 3.05M | — | $34.31M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 3.05M | — | $34.31M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 3.05M | — | $34.31M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (passief) | 3.05M | — | $34.31M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (passief) | 3.05M | — | $34.31M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | The Vanguard Group ✦ (passief) | 2.38M | — | $26.79M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | The Vanguard Group ✦ (passief) | 2.38M | — | $26.79M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | The Vanguard Group ✦ (passief) | 2.38M | — | $26.79M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | The Vanguard Group ✦ (passief) | 2.38M | — | $26.79M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | The Vanguard Group ✦ (passief) | 2.38M | — | $26.79M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | The Vanguard Group ✦ (passief) | 2.38M | — | $26.79M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Millennium Management ✦ | 1.35M | -5.1% | $15.24M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 27 | Geode Capital Management ✦ (passief) | 937.58K | +104.5% | $10.55M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | Geode Capital Management ✦ (passief) | 937.58K | +104.5% | $10.55M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | State Street Global Advisors ✦ (passief) | 741.05K | +121.0% | $8.34M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 30 | Two Sigma Investments ✦ | 203.61K | -35.2% | $2.29M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 31 | AQR Capital Management ✦ | 163.79K | +3.0% | $1.84M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | AQR Capital Management ✦ | 163.79K | +3.0% | $1.84M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 163.79K | +3.0% | $1.84M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 163.79K | +3.0% | $1.84M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 163.79K | +3.0% | $1.84M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 36 | Glenview Capital ✦ | 149.38K | -20.3% | $1.68M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 37 | T. Rowe Price ✦ | 87.89K | +18.3% | $990,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 38 | T. Rowe Price ✦ | 87.89K | +18.3% | $990,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 39 | D. E. Shaw & Co. ✦ | 59.77K | Nieuw | $672,424 | 0.0% | New | 1 | SEC ↗ |
| 40 | Citadel Advisors ✦ | 10.11K | Nieuw | $113,783 | 0.0% | New | 1 | SEC ↗ |
| 41 | Fidelity (FMR) ✦ | 2.52K | — | $28,310 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Fidelity (FMR) ✦ | 2.52K | — | $28,310 | 0.0% | n/c | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| D. E. Shaw & Co. | $672,424 | 0.0% |
| Citadel Advisors | $113,783 | 0.0% |
Verlaten
| Marshall Wace | $1.50M | was 0.0% |
| Point72 Asset Management | $416,670 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1 houders, 140 aandelen, $0 gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 330 aand · $2,302
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie